The immunogenicity of a single dose of a whole-cell vaccine of inactivated Borrelia burgdorferi1HSF (human spinal fluid isolate) was evaluated. Syrian hamsters were vaccinated subcutaneously and challenged by the intraperitoneal injection of 1,000 50% infectious doses of B. burgdorferi HSF 30 or 90 days postvaccination.
Lyme borreliosis (Lyme disease and related disorders) is a zoonosis characterized by a number of variable syndromes (2, 11, 20) . The etiological agent of this disease is Borrelia burgdorferi (4, 14, 19) , which is primarily transmitted by Ixodes ticks (1, (5) (6) (7) (8) 18 ). Lyme disease is presently the most commonly reported tick-borne disease in the United States (9) .
Control of Lyme borreliosis, a tick-borne zoonosis, is difficult. Elimination of the rodent reservoir, such as the white-footed mouse, is impractical, and deer herd size reduction would only be applicable on a local basis. Largescale use of acaricides, especially in suburban areas, is generally unacceptable and is of questionable effectiveness. Vaccination of high-risk individuals and of susceptible domestic animals could be a practical measure for the prevention of Lyme disease. We performed vaccine trials with the Syrian hamster as the experimental animal. The Syrian hamster is useful for studying experimental infection by B. burgdorferi (10, 13) . Our studies on the passive protection of hamsters against experimental infection with B. burgdorferi indicated that circulating antibodies play a major role in immunity to this illness (12) .
B. burgdorferi HSF (originally isolated from human spinal fluid [19] 
